The Great Disruption: Inside Jay Bhattacharya’s Contentious Tenure at the NIH

Eighteen months into his tenure as director of the National Institutes of Health (NIH), Jay Bhattacharya finds himself at the center of a deepening storm. Tasked with restoring public confidence in the nation’s premier biomedical research agency, the former Stanford health policy professor has instead become the lightning rod for a massive internal and external backlash. While Bhattacharya frames his mandate as the "depoliticization" of federal science, a growing coalition of current and former NIH employees, researchers, and grant advocates warn that his leadership is actively dismantling the foundations of American scientific inquiry.

The Mandate vs. The Reality

Bhattacharya’s rhetoric remains consistently focused on a singular theme: the NIH had, over the last fifteen years, become a partisan entity. In a recent interview with the conservative platform PragerU, he dismissed mounting criticism of his policies as a failure to grasp the “big picture.”

“What came before was politicization,” Bhattacharya asserted. “What we’re doing now is depoliticization.”

His stated platform included ambitious goals: funding only the most meritorious science, eliminating ideological decision-making, lowering barriers for younger investigators, and fostering a culture of rigorous replication studies. However, nearly a year and a half after his Senate confirmation, the reality on the ground appears to diverge sharply from these promises.

Staff members report a climate of fear, characterized by the summary termination or suspension of thousands of research grants. While legal challenges have restored some of these awards, data from Grant Witness, an independent watchdog, indicates that more than 1,200 research projects remain in a state of indefinite disruption. Furthermore, his long-promised in-house journal for replication studies has yet to materialize, and internal disputes over the existence of "banned word" lists have left staff questioning the agency’s transparency.

A Chronology of Conflict

The friction between the director and his workforce has been building since early 2025. The following timeline outlines the key markers of this turbulent period:

• Early 2025: The NIH begins an aggressive review of its grant portfolio, citing a need to align research with "agency priorities."
• June 2025: The "Bethesda Declaration" is published, a public letter from NIH staff members denouncing the wave of grant terminations and perceived ideological overreach.
• February 2026: Bhattacharya is appointed acting director of the Centers for Disease Control and Prevention (CDC), sparking concerns about the consolidation of power across federal health agencies.
• March 2026: The NIH launches the "Scientific Freedom Lecture Series," which critics argue functions more as a platform for contrarian views than as a neutral scientific forum.
• May 2026: The firing of probationary employees, including Anna Culbertson, triggers further outrage and leads to the formation of advocacy groups like 27 UNIHTED.
• June 2026: A follow-up report, The Bethesda Declaration: One Year Later, is released, accusing the director of gaslighting the scientific community.

The Erosion of Peer Review and Data Transparency

Perhaps the most significant structural change under Bhattacharya’s leadership is the systematic downgrading of the peer-review process. The NIH, which manages an annual budget exceeding $47 billion, has traditionally relied on rigorous peer-review scores to determine the allocation of taxpayer funds.

The agency recently announced plans to stop disclosing "final overall impact scores" and percentile rankings to applicants and even to many internal advisory councils. In their place, the agency will utilize broad categories: "most competitive," "competitive," and "not discussed."

Critics argue that this "binning" of applications renders a top-tier grant indistinguishable from one on the lower end of the spectrum, stripping the system of its quantitative precision. "The idea that you would score something and then not tell what the score was is just crazy," said Jennifer Troyer, former NIH extramural operations division director.

Jenna Norton, an NIH program officer and author of the Bethesda Declaration, suggests that this lack of transparency is a strategic move to facilitate political interference. "Bhattacharya is like the fireman who ended up being an arsonist," said Scott Delaney, co-founder of Grant Witness. "The data suggests that current leadership has not been successful in implementing any of their stated priorities for early-career researchers or geographical distribution of funds."

The "Banned Words" Controversy

Bhattacharya has repeatedly denied the existence of a prohibited vocabulary at the NIH. However, documents obtained by Inside Higher Ed and investigative reports reveal that the agency has utilized computational text analysis tools to scan grant applications for terms deemed "misaligned" with agency priorities.

Guidance provided to staff suggests that terms like "health equity" and "structural racism" are targets for "renegotiation" or outright cancellation if the premise of the research is deemed "subjective." A report from the Democratic minority on the Senate HELP Committee highlighted a broader list of flagged terms, including "climate change," "gender," "COVID," and "vaccine acceptance."

Bhattacharya defends these tools as necessary for identifying "politicized DEI" (Diversity, Equity, and Inclusion) initiatives. "We’d just negotiate with the scientists who are relieved to remove the political nonsense," he stated in his PragerU interview. Yet, for researchers whose life’s work involves studying health disparities, these "negotiations" have often resulted in the permanent loss of funding.

Impact on Early-Career Researchers

The fallout from these policy shifts has disproportionately affected the next generation of scientists. NIH data shows a marked decline in the success rate of Early-Stage Investigators (ESIs). In 2024, approximately 1,423 ESIs received R01-equivalent grants; in 2025, that number plummeted to 1,114, despite an increase in the total number of applicants.

The agency’s pivot toward "forward-funded" or multiyear grants has locked in funding for existing projects, leaving a smaller pool of resources for new research. Programs designed to promote diversity, such as the Maximizing Opportunities for Scientific and Academic Independent Careers program, were shuttered, with existing grants terminated regardless of their scientific merit or progress.

The COVID-19 Hangover

Bhattacharya’s tenure is also defined by a persistent fixation on the COVID-19 pandemic. During his brief stint as acting director of the CDC, he blocked the publication of an internal study that suggested high efficacy for the 2025-26 COVID-19 vaccines, citing concerns over methodology. The study was eventually published by JAMA Network Open despite the agency’s opposition.

His "Scientific Freedom Lecture Series" at the NIH has featured speakers who have questioned established pandemic narratives, including those promoting the lab-leak theory. Bhattacharya maintains that the pandemic’s impact is the defining challenge of the era. "We still are in the COVID hangover period," he remarked. "Grappling with that is the central question of this age."

Implications for Public Trust

The most damning metric of Bhattacharya’s leadership may be the decline in public confidence. Annenberg Public Policy Center surveys show that trust in the NIH has dropped from 74 percent in September 2024 to 62 percent as of late 2026. The decline is most pronounced among Democrats, but the general trend suggests a broad fragmentation of faith in federal health authorities.

A spring poll by the de Beaumont Foundation and the Harvard T. H. Chan School of Public Health found that 53 percent of Americans distrust federal public health recommendations more now than they did before the current administration took office.

As Anna Culbertson, former NIH employee and executive director of 27 UNIHTED, put it: "He’s doing a good job at communicating—he’s just communicating misinformation."

For the scientific community, the long-term cost of these policies remains the primary concern. As the Bethesda Declaration authors noted, the damage done to the agency’s reputation and its relationship with the American public may take decades to repair. Whether Bhattacharya’s vision of a "depoliticized" NIH can coexist with the rigorous, transparent, and evidence-based standards that have defined the agency for generations remains the central, and perhaps unanswerable, question of his tenure.